ES2009251A6 - Un metodo de obtencion de una composicion anticonceptiva para la mujer - Google Patents

Un metodo de obtencion de una composicion anticonceptiva para la mujer

Info

Publication number
ES2009251A6
ES2009251A6 ES8800883A ES8800883A ES2009251A6 ES 2009251 A6 ES2009251 A6 ES 2009251A6 ES 8800883 A ES8800883 A ES 8800883A ES 8800883 A ES8800883 A ES 8800883A ES 2009251 A6 ES2009251 A6 ES 2009251A6
Authority
ES
Spain
Prior art keywords
women
obtaining
contraceptive composition
contraceptive
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8800883A
Other languages
English (en)
Inventor
Michael Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Medical Research Inc
Applied Medical Research Ltd
Original Assignee
Applied Medical Research Inc
Applied Medical Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Medical Research Inc, Applied Medical Research Ltd filed Critical Applied Medical Research Inc
Publication of ES2009251A6 publication Critical patent/ES2009251A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

UN METODO DE OBTENCION DE UNA COMPOSICION ANTICONCEPTIVA PARA LA MUJER, CARACTERIZADO PORQUE COMPRENDE COMBINAR UNA CANTIDAD ANTICONCEPTIVAMENTE EFICAZ DE MELATONINA CON UN EXCIPIENTE FARMACEUTICAMENTE ACEPTABLE; Y LLENAR ENTONCES CAPSULAS DE GELATINA CON LA MEZCLA RESULTANTE.
ES8800883A 1987-03-23 1988-03-23 Un metodo de obtencion de una composicion anticonceptiva para la mujer Expired ES2009251A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/029,229 US4855305A (en) 1987-03-23 1987-03-23 Compositions and methods of effecting contraception utilizing melatonin

Publications (1)

Publication Number Publication Date
ES2009251A6 true ES2009251A6 (es) 1989-09-16

Family

ID=21847942

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8800883A Expired ES2009251A6 (es) 1987-03-23 1988-03-23 Un metodo de obtencion de una composicion anticonceptiva para la mujer

Country Status (26)

Country Link
US (1) US4855305A (es)
EP (1) EP0354921B1 (es)
JP (2) JP2965160B2 (es)
KR (1) KR890700349A (es)
CN (1) CN1041383C (es)
AT (1) ATE143807T1 (es)
AU (3) AU628784B2 (es)
BG (1) BG51075A1 (es)
BR (1) BR8807426A (es)
CA (1) CA1322527C (es)
DD (1) DD269557A5 (es)
DE (1) DE3855606T2 (es)
EG (1) EG18583A (es)
ES (1) ES2009251A6 (es)
FI (1) FI894423L (es)
GR (1) GR1002146B (es)
HU (1) HU208487B (es)
IL (1) IL85814A (es)
IN (1) IN166946B (es)
NZ (1) NZ223989A (es)
OA (1) OA09134A (es)
PH (1) PH26709A (es)
PT (1) PT87053B (es)
RU (1) RU2114621C1 (es)
WO (1) WO1988007370A1 (es)
ZA (1) ZA882079B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001395B (el) * 1987-03-23 1993-10-29 Michael Cohen Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
EP0300630A3 (en) * 1987-07-03 1990-03-28 Schering Agrochemicals Limited Melatonin for regulating animal reproduction
EP0305194A3 (en) * 1987-08-28 1990-03-28 Schering Agrochemicals Limited Veterinary composition
GR900100024A (el) * 1989-01-17 1991-06-07 Amr Int Μέθοδος θεραπείας του προεμμηνορροϊκού συνδρόμου.
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
IN170311B (es) * 1989-01-17 1992-03-14 Cohen Michael
NZ233697A (en) * 1989-05-17 1996-12-20 Applied Med Res Ltd Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen
AU644367B2 (en) * 1989-05-17 1993-12-09 Applied Medical Research Ltd Use of melatonin derivatives for effecting contraception
IT1243193B (it) * 1990-08-10 1994-05-24 Medea Res Srl Composizioni farmaceutiche orali a base di melatonina
EP0641565B1 (en) * 1990-09-28 2000-03-15 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi Contraceptive and menstrual cycle controlling drug having oncostatic properties
DE69229490T2 (de) * 1991-05-09 2000-02-17 Neurim Pharmaceuticals (1991) Ltd., Tel Aviv Melatonin enthaltende Arzneimittel
AU660336B2 (en) * 1991-10-18 1995-06-22 Alza Corporation Device for the transdermal administration of melatonin
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IL105240A (en) * 1992-04-07 1999-04-11 Neurim Pharma 1991 The use of melatonin in the preparation of a drug for the treatment of benign prostatic hyperplasia
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
US6403631B1 (en) 1995-11-24 2002-06-11 Equitech Laboratories, Inc. Method and compositions for enhancing pregnancy success in an animal
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6620836B1 (en) * 1997-01-22 2003-09-16 Jay Patrick Antiarrhythmic and tranquilizer composition and treatment
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
TR200001334T2 (tr) 1997-11-14 2000-09-21 Akzo Nobel N.V. Progestojen-anti-progestojen rejimleri.
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
PT1315502E (pt) * 2000-08-30 2010-05-06 Unimed Pharmaceuticals Llc Método para tratar a disfunção eréctil e para aumentar a líbido em homens
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
WO2003077900A1 (en) * 2002-03-14 2003-09-25 Prevention, L.L.C. A unifying mechanism and methods to prevent cancer and neurodegenerative diseases
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP1622623A4 (en) * 2003-04-11 2009-03-18 Barr Lab Inc METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
CA2526586C (en) 2003-09-09 2010-03-16 Biogen International Gmbh The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
WO2005117898A1 (en) * 2004-05-26 2005-12-15 Wyeth Compositions and methods for treatment of premenstrual dysphoric disorder
EP1799196B1 (en) 2004-10-08 2016-06-22 Forward Pharma A/S Controlled release pharmaceutical compositions comprising a fumaric acid ester
DK2450041T3 (en) 2005-10-12 2018-11-19 Unimed Pharmaceuticals Llc Enhanced testosterone gel for use in the treatment of hypogonadism
WO2008032238A2 (en) * 2006-09-13 2008-03-20 Koninklijke Philips Electronics N. V. Device for automatic adjustment of the dose of melatonin and/or delivery of melatonin
EP2680006A1 (en) 2007-02-08 2014-01-01 Biogen Idec MA Inc. Treatment for Amyotrophic Lateral Sclerosis
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
FR2937862B1 (fr) * 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
WO2015144965A1 (es) * 2014-03-27 2015-10-01 Servicio Andaluz De Salud Preparación duradera de inyectable de melatonina estable a largo plazo
RU2617518C2 (ru) * 2015-07-01 2017-04-25 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения и контрацепции самок млекопитающих
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
EP0004770B1 (en) * 1978-04-11 1984-06-13 Efamol Limited Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
JPH0778007B2 (ja) * 1985-03-04 1995-08-23 セレ−ナ （セル・エンジニアリング） ア−・ゲ− メラトニン組成物とその使用
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors

Also Published As

Publication number Publication date
OA09134A (en) 1991-10-31
IL85814A (en) 1992-05-25
JPH02502724A (ja) 1990-08-30
AU1683088A (en) 1988-11-02
JPH1171276A (ja) 1999-03-16
US4855305A (en) 1989-08-08
FI894423A7 (fi) 1989-09-19
DD269557A5 (de) 1989-07-05
CN88101379A (zh) 1988-10-05
CA1322527C (en) 1993-09-28
AU8693891A (en) 1991-12-19
FI894423A0 (fi) 1989-09-19
EP0354921A1 (en) 1990-02-21
GR880100177A (el) 1989-01-31
NZ223989A (en) 1991-08-27
FI894423L (fi) 1989-09-19
RU2114621C1 (ru) 1998-07-10
EP0354921A4 (en) 1991-08-07
PT87053B (pt) 1993-09-30
IL85814A0 (en) 1990-02-09
ZA882079B (en) 1988-09-15
JP2965160B2 (ja) 1999-10-18
DE3855606T2 (de) 1997-02-13
EP0354921B1 (en) 1996-10-09
HUT52954A (en) 1990-09-28
AU5513494A (en) 1994-04-14
EG18583A (en) 1993-06-30
IN166946B (es) 1990-08-11
PT87053A (pt) 1989-03-30
ATE143807T1 (de) 1996-10-15
WO1988007370A1 (en) 1988-10-06
BR8807426A (pt) 1990-04-10
GR1002146B (en) 1996-02-19
KR890700349A (ko) 1989-04-24
AU676523B2 (en) 1997-03-13
DE3855606D1 (de) 1996-11-14
BG51075A1 (en) 1993-02-15
HU208487B (en) 1993-11-29
CN1041383C (zh) 1998-12-30
AU628784B2 (en) 1992-09-24
PH26709A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
ES2009251A6 (es) Un metodo de obtencion de una composicion anticonceptiva para la mujer
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
ATE198835T1 (de) Knochenwachstumsfördernde zusammensetzung
LU88750I2 (fr) VENLAFAXINE et ses dérivés pharmaceutiquement acceptables
IT8667697A0 (it) Procedimento per formare in situ una composizione costituita da due parti confezionate separatamente e gruppo distributore per l attuazione del procedimento
DE3171774D1 (en) Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
ES2010226A6 (es) Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos
ES2044087T3 (es) Un metodo para preparar una composicion de 13,14-dihidro-15-cetoprostaglandina estabilizada.
ES523536A0 (es) "un metodo para preparar una mezcla farmaceutica con liberacion controlada de sustancia activa"
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
ES2057225T3 (es) Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion.
FI91964C (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi
MY101029A (en) Bromocriptine compositions
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
IT9022439A0 (it) Derivati del glicerolo un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
FI811889A7 (fi) Menetelmä farmaseuttisesti aktiivisten indoli- ja indoliinijohdannaisten valmistamiseksi.
DE2860796D1 (en) Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them
PT77793A (en) Process for the preparation of analgesic pharmaceutical compositions containing a combination of 1-(p-chlorobenzlydryl)-4-<2-(2-hydroxyethoxy)-ethyl>-diethylenediamine with one or more non esteroidal antiinflamatory/analgesic agents
IT1183053B (it) Derivati dell'alfa-amino-gamma-butirrolatton e, metodo per prepararli e composizioni farmaceutiche che li contengono
ES8705223A1 (es) Procedimiento para la obtencion de una composicion retardada a base de bromocriptina.
AR231074A1 (es) Composicion excipiente para una sustancia ingerible por via oral,y procedimiento para su preparacion
IT8219216A0 (it) Ne e relative composizioni farmaceu composto ad attivita' antiinfiammatiche toria,analgesica e mucoregolatrice, procedimento per la sua preparazio-
IT1235760B (it) Derivati del catecolo, procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IT8721055A0 (it) Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
IT8622783A0 (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050326